Annotation Detail
Information
- Associated Genes
- TOX3
- Associated Variants
-
FGFR2 c.109+906T>C
(
ENST00000683211.1,
ENST00000357555.9,
ENST00000683035.1,
ENST00000346997.6,
ENST00000369061.8,
ENST00000457416.7,
ENST00000356226.8,
ENST00000684153.1,
ENST00000611527.1,
ENST00000682550.1,
ENST00000613048.4,
ENST00000359354.6,
ENST00000369056.5,
ENST00000360144.7,
ENST00000369059.5,
ENST00000351936.11,
ENST00000369060.8,
ENST00000358487.10 )
rs3803662
NC_000006.12:g.151627231G>A
FGFR2 c.109+906T>C ( ENST00000683211.1, ENST00000684153.1, ENST00000346997.6, ENST00000351936.11, ENST00000356226.8, ENST00000357555.9, ENST00000358487.10, ENST00000359354.6, ENST00000360144.7, ENST00000369056.5, ENST00000369059.5, ENST00000369060.8, ENST00000369061.8, ENST00000457416.7, ENST00000611527.1, ENST00000613048.4, ENST00000682550.1, ENST00000683035.1 )
rs3803662
NC_000006.12:g.151627231G>A - Associated Disease
- Carcinoma of male breast
- Source Database
- DisGeNET
- Description
- By multivariate logistic regression models, we found a significant increased MBC risk for 3 SNPs, in particular, with codominant models, for rs2046210/ESR1 (OR = 1.71; 95 % CI: 1.43-2.05; p = 0.0001), rs3803662/TOX3 (OR = 1.59; 95 % CI: 1.32-1.92; p = 0.0001), and rs2981582/FGFR2 (OR = 1.26; 95 % CI: 1.05-1.50; p = 0.013).
- Pubmed
- 23468243
- Original source reporting the Gene Disease association
- BeFree
- DisGENET score for the Gene Disease association
- 0.000542883744160607
- Year of publication
- 2013
Drugs